A clinical experience of using extracorporeal cytokine adsorption device (CytoSorb) in a case of Dengue fever

Khan, Z.A. Noble Hospital, Magarpatta Road, Hadapsar, Pune-411028, India.


This case study reports on a 32 year old male patient who was transferred to atertiary ICU with worsening multi organ failure, after presenting to a local hospital with fever, chills, dyspnea, yellow discoloration of skin and sclera the previous week


Case presentation

  • On admission the patient was pyrexic (100oF, heart rate 120 – 130 bpm, respiratory rate 26 – 30 per min, leukocytosis 16,400 µl, with acute organ dysfunction (agitation, thrombocytopenia, hypoxia, kidney dysfunction, metabolic acidosis and arterial hypotension), sepsis and septic shock. His APACHE score on admission was 27.
  • Within 24 hours the patient needed to be mechanically ventilated because of worsening Acute Respiratory Distress Syndrome (ARDS) and hypoxia
  • The patient received fluid optimization, nutritional support, antibiotics, proton pump inhibitors, treatments for hepatic encephalopathy, blood products and other standard support therapy


  • CytoSorb was added as a supportive therapy due to the systemic inflammatory response and multiple organ dysfunction
  • The patient received three sessions of six hours each on days 2, 4 and 6 of admission.
  • No anticoagulation was used, blood flow rate was 250 mL/min


  • Clinical and laboratory parameters before and after CytoSorb treatment: Creatinine, hematocrit, leucocytes, platelets, mean arterial pressure (MAP), ARF – Acute Renal Failure, GCS – Glasgow Coma Scale, aPTT – Activated Partial Thromboplastin Time, GOT – Serum Glutamic Oxaloacetic Transaminase (AST), GPT – Serum Glutamic Pyruvic Transaminase (ALT)
  • Arterial blood gas values before and after CytoSorb therapy: pH, PaCO2 – Partial Pressure of Carbon Dioxide, PaO2 – Partial Pressure of Oxygen, SBC – Standard Bicarbonate, (A-a) O2 – Alveolar-arterial oxygen gradient mmHg, Base Excess


  • There were no major complications during or after the CytoSorb therapy except mild irritability that settled with sedatives
  • Patient showed gradual improvement with APACHE score after the third cycle decreasing from 27 to 12
  • As a result of the treatment:
    • Creatinine decreased from 3.96 to 1.59 mg/dL
    • Leucocytes from 16,3000 to 13,000 /µL
    • Platelets from 50,000 to 311,000 /µL
    • GCS from 9 to >10
    • Mean arterial pressure from 84 to 104 mmHg
    • aPTT from 43 to > 60 seconds, GOT (AST) from 15690 to 156 U/L, GPT (ALT) from 3910 to 84 U/L
    • Serum lactate from 6.7 to 1.9 mmol/L

Post-treatment period and follow-up

  • Patient was transferred from ICU on day 13, and subsequently discharged fully ambulant.


  • CytoSorb helped to stabilize and revive this patient with dengue, MODS and shock.
  • The majority of laboratory parameters were within the normal range after the therapy and no major adverse events were reported during or after the CytoSorb therapy.
  • This is the first report of the clinical application of CytoSorb hemoadsorption in a case of dengue fever with MODS treated successfully with standard of care along with CytoSorb
  • CytoSorb seems to be an interesting and safe option to stabilize and help dengue patients with MODS to recover